The first week of 2019 looks a lot like 2018 in at least one regard: A Big Pharma company’s commercial head is on the move. This time it’s Mark Mallon, AstraZeneca’s EVP of global product and portfolio strategy, and he’ll be taking up the CEO’s spot at newly revamped Ironwood.
